What is the role of NT-proBNP in COVID -19?

Dr Januzzi : COVID-19 may manifest from a cardiac perspective in a number of different ways – atrial fibrillation is common, heart muscle dysfunction whether related to myocarditis (which is probably a little bit more uncommon, but may still happen or not) and stress cardiomyopathy. There is also triggering of ischaemic heart disease and other […]

Read More…

What is the role of natriuretic peptides testing in patients with diabetes to identify risk? Would that help you make decisions about which drugs you might want to give them?

Dr Sim: There is no clear guideline, especially in the Asian setting like, after X number of years of diabetes, we should start doing NT-proBNP. The traditional way of treating diabetes is just checking on HbA1c, and then wait till the patient develops coronary artery disease or heart failure. Then treatment initiated is with a […]

Read More…

The decrease of NT-proBNP, 30% or more, from admission to discharge indicates the patient will have a better prognosis. For the obese patient, can we use the same logic?

Dr Januzzi: Analyses shows that obesity did not affect the prognostic meaning of the 30% reduction during hospitalisation. Although obesity suppresses natriuretic peptide, when an obese patient is admitted for heart failure, they usually have elevated values. It is just that they are not as high as one might expect. The reduction is largely the same. […]

Read More…

2800+ Healthcare Professionals have cardiac insights delivered to their inbox
Sign up to receive the latest updates via your email
Keep me informed